Glucosamine and chondroitin for osteoarthritis?
Glucosamine and chondroitin for osteoarthritis?
McAlindon et al., 2001 | Bull Rheum Dis | Meta Analysis
Citation
McAlindon T. Glucosamine and chondroitin for osteoarthritis?. Bull Rheum Dis. 2001-Jul;50(7):1-4
Abstract
The current body of evidence currently supports modest efficacy for glucosamine and chondroitin in the treatment of OA symptoms. The products are safe and could play a valuable role in the management of this disorder. Nevertheless, further independent studies are needed to confirm these findings and to determine the clinical applicability of these compounds. Physicians need to become involved in these treatment decisions but are confused by wide variability in the formulation and purity of the numerous preparations available to consumers. The notion that glucosamine and chondroitin might have disease-modifying effects in OA is highly appealing and supported by preliminary data. Research is needed to confirm these findings and to evaluate the impact of glucosamine and chondroitin on all aspects of OA progression.
Key Findings
Research is needed to confirm these findings and to evaluate the impact of glucosamine and chondroitin on all aspects of OA progression.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Chondroitin
- Dietary Supplements
- Glucosamine
- Humans
- Osteoarthritis
- Safety
Evidence Classification
- Level: Meta Analysis
- Publication Types: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't
- Vertical: glucosamine
Provenance
- PMID: 11530541
- DOI: (not available)
- PMCID: Not in PMC
- Verified: 2026-04-10 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-10